Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia
- PMID: 22353957
- PMCID: PMC3285255
- DOI: 10.1097/AOG.0b013e318244ee3d
Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia
Abstract
Objective: To estimate the prevalence, incidence, and clearance of abnormal vaginal cytology and vaginal intraepithelial neoplasia (VAIN) in human immunodeficiency virus (HIV)-seropositive women.
Methods: Pap tests were done semiannually for 335 HIV-seropositive and 75 HIV-seronegative women with prior hysterectomy in the prospective Women's Interagency HIV Study cohort. End points included abnormal Pap test results after hysterectomy and VAIN regardless of hysterectomy.
Results: Over a median of 5.6 years of follow-up, vaginal Pap test results were abnormal at 1,076 (29%; 95% confidence interval [CI] 25-33%) of 3,700 visits among HIV-seropositive compared with 31 (4%; 95% CI 2-8%) of 763 visits among HIV-seronegative women (P<.001). Abnormal Pap test results included 641 atypical squamous cells of undetermined significance, 425 low-grade squamous intraepithelial lesions, and 10 high-grade squamous intraepithelial lesions in HIV-seropositive women and 28 atypical squamous cells of undetermined significance and three low-grade squamous intraepithelial lesions in HIV-seronegative women. The incidence of abnormal Pap test results after hysterectomy was 14 per 100 person-years among HIV-seropositive and two per 100 person-years among HIV-seronegative women (P<.001) and remained stable across time. The 5-year clearance rate of abnormal Pap test results was 34 per 100 person-years for HIV-seropositive and 116 per 100 person-years for HIV-seronegative women (P<.001). In multivariate regression models, women with lower CD4 counts were more likely to have and less likely to clear abnormal cytology when it occurred. The incidence of VAIN 2 or worse was 0.2 and 0.01 per 100 person-years for HIV-seropositive and HIV-seronegative women (P=.001). Two HIV-seropositive women developed stage II cancers with remission after radiotherapy.
Conclusion: Vaginal Pap test results are often abnormal in HIV-seropositive women. Although more common than in HIV-seronegative women, VAIN 2 or worse and especially vaginal cancers are infrequent.
Conflict of interest statement
The other authors did not report any potential conflicts of interest.
Figures
Similar articles
-
Abnormal Vaginal Pap Test Results After Hysterectomy in Human Immunodeficiency Virus-Infected Women.Obstet Gynecol. 2016 Jul;128(1):52-57. doi: 10.1097/AOG.0000000000001457. Obstet Gynecol. 2016. PMID: 27275815
-
Vaginal intraepithelial neoplasia in patients after total hysterectomy.Curr Probl Cancer. 2021 Jun;45(3):100687. doi: 10.1016/j.currproblcancer.2020.100687. Epub 2020 Dec 4. Curr Probl Cancer. 2021. PMID: 33309077
-
Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.Am J Obstet Gynecol. 2020 May;222(5):486.e1-486.e10. doi: 10.1016/j.ajog.2019.10.011. Epub 2019 Oct 31. Am J Obstet Gynecol. 2020. PMID: 31678094
-
Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: A retrospective study of 118 patients.J Obstet Gynaecol Res. 2021 May;47(5):1624-1630. doi: 10.1111/jog.14733. Epub 2021 Mar 23. J Obstet Gynaecol Res. 2021. PMID: 33754436 Review.
-
Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management.Obstet Gynecol Surv. 1999 Feb;54(2):131-7. doi: 10.1097/00006254-199902000-00023. Obstet Gynecol Surv. 1999. PMID: 9950005 Review.
Cited by
-
Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.Am J Obstet Gynecol. 2021 Oct;225(4):411.e1-411.e7. doi: 10.1016/j.ajog.2021.04.253. Epub 2021 May 3. Am J Obstet Gynecol. 2021. PMID: 33957115 Free PMC article.
-
Risk of cervical and vaginal dysplasia after surgery for vulvar intraepithelial neoplasia or cancer: A 6 year follow-up study.Gynecol Oncol. 2019 Oct;155(1):88-92. doi: 10.1016/j.ygyno.2019.07.017. Epub 2019 Jul 30. Gynecol Oncol. 2019. PMID: 31375270 Free PMC article.
-
Is robotic-assisted vaginectomy a better choice in vaginal high-grade squamous intraepithelial lesions than conventional laparoscopic surgery?BMC Womens Health. 2024 Jan 13;24(1):36. doi: 10.1186/s12905-024-02882-x. BMC Womens Health. 2024. PMID: 38218831 Free PMC article.
-
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the Management of Vaginal Intraepithelial Neoplasia.J Low Genit Tract Dis. 2023 Apr 1;27(2):131-145. doi: 10.1097/LGT.0000000000000732. J Low Genit Tract Dis. 2023. PMID: 36951985 Free PMC article.
-
Vaginal Dysplasia and HIV: An African American and Caribbean American Cohort Study.Interdiscip Perspect Infect Dis. 2019 Jan 1;2019:6189837. doi: 10.1155/2019/6189837. eCollection 2019. Interdiscip Perspect Infect Dis. 2019. PMID: 30693024 Free PMC article.
References
-
- Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in Human Immunodeficiency Virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst. 1999;91:226–36. - PubMed
-
- Massad LS, Seaberg EC, Wright RL, Darragh T, Lee YC, Colie C, et al. Squamous cervical lesions in women with Human Immunodeficiency Virus: long-term follow up. Obstet Gynecol. 2008;111:1388–93. - PubMed
-
- Massad LS, Evans C, Weber K, Cejtin HE, Golub ET, DiGilio K, et al. Hysterectomy among women with HIV: Indications and Incidence. J AIDS. 2007;44:566–68. - PubMed
-
- D’Souza G*, Burk RD, Zhong Y, Minkoff H, Massad LS, Xue X, et al. Cervicovaginal HPV Infection Before and After Hysterectomy: Evidence of Different Tissue Tropism for Oncogenic and Non-Oncogenic HPV Types in a Cohort of HIV-positive and HIV-negative Women. Internat J Cancer. In press. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- U01-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- R01-CA-085178/CA/NCI NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- R01 CA085178/CA/NCI NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U01-AI-34989/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials